Progress in application of positron emission tomography/computed tomography (PET/CT) imaging in tumor screening / 中国辐射卫生
Chinese Journal of Radiological Health
; (6): 66-69, 2023.
Article
in Zh
| WPRIM
| ID: wpr-965375
Responsible library:
WPRO
ABSTRACT
@#Worldwide, the incidence of cancer is greatest in China. Tumor screening is effective to achieve early diagnosis, improve prognosis, increase the quality of life, and reduce mortality among cancer patients. Positron emission tomography/computed tomography (PET/CT) imaging provides metabolic data to support initial staging, treatment planning, and response evaluation in tumor screening, as well as tumor follow-up. The progressive integration of PET/CT imaging in radiotherapy has its basic principle in the biological heterogeneity of inter- and intra-tumor malignant lesions, and the radiation dose is required to be adjusted to achieve effective local tumor control among cancer patients. In addition, PET/CT imaging provides data on the biological features of tumor lesions, such as metabolism, hypoxia, and proliferation, which is useful to identify radiation-resistant regions and optimize treatment plans. These data are effective to reduce the uncertainty and variability in the anatomic description of tumor sites. This review summarizes the application of PET/CT imaging in common tumors.
Full text:
1
Database:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Radiological Health
Year:
2023
Document type:
Article